Trial intelligence / Profile preview

Donepezil added to methadone maintenance therapy for opioid-dependent adults

IRCT20191217045766N1Phase 3Completed

Sponsor
Kurdistan University of Medical Sciences
Start
Dec 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of donepezil in opioid use disorder (OUD) (2 arms), sponsored by Kurdistan University of Medical Sciences. Primary endpoints: Opioid craving and Methadone intake. Started Dec 2021; status: completed.

02

Drugs

donepezil
03

Conditions

opioid use disorder (OUD)

Beyond the preview

Go deeper on IRCT20191217045766N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20191217045766N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call